Community Health (CYH)
RBC Capital analyst Ben Hendrix maintained a Buy rating on Community Health yesterday and set a price target of $21.00. The company’s shares closed last Tuesday at $13.74.
According to TipRanks.com, Hendrix is a 1-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Community Health with a $16.92 average price target, which is a 24.9% upside from current levels. In a report issued on January 10, Citigroup also upgraded the stock to Buy with a $18.00 price target.
ATAI Life Sciences (ATAI)
In a report released yesterday, Brian Abrahams from RBC Capital maintained a Hold rating on ATAI Life Sciences, with a price target of $12.00. The company’s shares closed last Tuesday at $5.39, close to its 52-week low of $5.29.
According to TipRanks.com, Abrahams is a 1-star analyst with an average return of
ATAI Life Sciences has an analyst consensus of Strong Buy, with a price target consensus of $29.50.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on CYH:
- Activist Investor Macellum Urges Kohl’s to Sell Company; Shares Up
- Coca-Cola Looks to Consolidate African Operations — Report
- Teva to Pay $420M to Settle Shareholders’ Generic Drug Pricing Lawsuit — Report
- ASML Holding Reports Strong Q4 Results
- Needham Thinks Enphase Energy’s Stock is Going to Recover